Global Leukocytosis Market Analysis (2026–2030) With Strategic Insights

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

How Will The Market Value Of The Leukocytosis Market Progress Between 2026 And 2030?

The leukocytosis market has demonstrated significant growth in recent years. It is projected to expand from $5.13 billion in 2025 to $5.41 billion in 2026, achieving a compound annual growth rate (CAGR) of 5.4%. This historical growth can be attributed to the high prevalence of infectious diseases, a rising incidence of inflammatory disorders, an increase in leukemia cases, continued reliance on conventional blood tests, and the broadening of hospital-based diagnostic services.

The leukocytosis market size is predicted to undergo significant expansion in the coming years. It is forecast to attain a value of $6.63 billion by 2030, advancing at a compound annual growth rate (CAGR) of 5.2%. This growth during the forecast period can be attributed to advancements in hematology diagnostics, rising adoption of personalized treatment approaches, growing awareness of early disease detection, increasing healthcare expenditure, and the expansion of laboratory automation. Prominent trends observed in the forecast period encompass increasing adoption of advanced blood diagnostics, growing focus on underlying disease-specific treatment, rising use of precision medicine in hematology, expansion of automated and high-throughput testing, and increasing integration of clinical decision support systems.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24278&type=smp

What Primary Drivers Are Shaping The Leukocytosis Market?

The increasing occurrence of blood-related diseases is anticipated to propel the expansion of the leukocytosis market in the coming years. These medical conditions affect components of the blood, including red blood cells, white blood cells, platelets, or plasma. The incidence of blood-related diseases is escalating due to aging populations, as older adults are more susceptible to conditions such as anemia, leukemia, and clotting disorders, resulting from diminishing immune function and accumulated health problems. Often, blood-related diseases lead to elevated white blood cell counts, a hallmark sign of leukocytosis, underscoring the demand for enhanced early diagnosis, improved monitoring tools, and more effective treatment options. For instance, in 2024, the American Cancer Society, a US-based cancer organization, documented 62,770 new cases of leukemia in 2024, a notable rise from 59,610 cases reported in 2023. Consequently, the escalating incidence of blood-related diseases is a key factor driving the growth of the leukocytosis market.

How Is The Leukocytosis Market Broken Down By Segment Categories?

The leukocytosis market covered in this report is segmented –

1) By Disease Type: Infection, Leukemia

2) By Diagnosis Type: Blood Tests, Bone Marrow Biopsy

3) By End User: Hospitals, Diagnostic Laboratories

Subsegments:

1) By Infection: Bacterial Infections, Viral Infections, Parasitic Infections, Fungal Infections

2) By Leukemia: Chronic Myeloid Leukemia, Chronic Lymphocytic Leukemia, Acute Lymphoblastic Leukemia (ALL) with Hyperleukocytosis

What Trends Are Affecting The Growth Of The Leukocytosis Market?

Companies actively engaged in the leukocytosis market are increasingly concentrating on embedding artificial intelligence into diagnostic systems to advance early identification, diagnostic exactness, and customized treatment blueprints. Artificial intelligence in diagnostic systems entails employing AI technologies such as machine learning, deep learning, and natural language processing to analyze health data and assist in or automate disease diagnosis. For example, in December 2024, Koninklijke Philips NV, a healthcare enterprise based in the Netherlands, released the CT 5300 system. This system integrates proprietary artificial intelligence technologies to refine computed tomography (CT) imaging operations. The CT 5300 system incorporates a smart workflow for computed tomography, utilizing AI-driven instruments like precise position, precise cardiac, and precise brain, which simplify scan preparation, boost diagnostic precision, and diminish radiation dosage.

Which Players Are Present In The Leukocytosis Market Space?

Major companies operating in the leukocytosis market are Pfizer Inc., Johnson & Johnson, Siemens Healthineers AG, Roche Diagnostics AG, Bristol Myers Squibb, Thermo Fisher Scientific Inc., Abbott Laboratories, Novartis International AG, Danaher Corporation, Merck KGaA, Becton Dickinson and Company (BD), Laboratory Corporation of America Holdings (LabCorp), Quest Diagnostics, Agilent Technologies Inc., Grifols SA, Hologic Inc., Illumina Inc., PerkinElmer Inc., Sysmex Corporation, Beckman Coulter Diagnostics Inc., Bio-Rad Laboratories, Bio-Techne Corporation, NeoGenomics Laboratories Inc., DiaSorin S.p.A.

Get The Full Leukocytosis Market Report:

https://www.thebusinessresearchcompany.com/report/leukocytosis-global-market-report

Which Region Accounts For The Largest Portion Of The Leukocytosis Market?

North America was the largest region in the leukocytosis market in 2025. Asia-Pacific is expected to be the fastest growing region in the forecast period. The regions covered in the leukocytosis market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Leukocytosis Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/leukocytosis-global-market-report

Browse Through More Reports Similar to the Global Leukocytosis Market 2026, By The Business Research Company

Progressive Multifocal Leukoencephalopathy Treatment Market Report 2026

https://www.thebusinessresearchcompany.com/report/progressive-multifocal-leukoencephalopathy-treatment-global-market-report

Pheochromocytoma Market Report

https://www.thebusinessresearchcompany.com/report/pheochromocytoma-global-market-report

Leukotriene Modifiers Market Report

https://www.thebusinessresearchcompany.com/report/leukotriene-modifiers-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795